Patient Blood Management Market

1
Patient Blood Management Market Size Worth USD
27.15 Billion by 2032
www.emergenresearch.com
Increasing frequency of target diseases, such as
anemia and iron deficiency, is a significant
factor driving global patient blood management
market revenue growth
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
The global Patient Blood Management (PBM)
market size is expected to reach USD 27.15
Billion in 2032 and register a steady revenue
CAGR of 7.4 during the forecast period,
according to latest analysis by Emergen Research.
Increasing frequency of target diseases, such as
anemia and iron deficiency, is a major factor
driving market revenue growth. For instance, the
important public health issue of anemia
disproportionately affects young children and
expectant mothers. According to World Health
Organization (WHO) statistics, anemia affects 40
of pregnant women and 42 of children under the
age of five globally. PBM mainly detects patients
who need blood transfusions and offers a
management strategy aiming at lowering or
eliminating risk of anemia and requirement for
allogeneic transfusion, hence lowering inherent
hazards, inventory pressures, and rising costs
related to transfusion, driving market revenue
growth High costs of automated systems, is a
major factor, which could restrain market revenue
growth. For example, cost of automation includes 
expense of instrument itself, price of training
and validation, and cost of ongoing use and
maintenance. The capital expenditure may range
from USD 50,000 to USD 250,000 depending on
capabilities and qualities of instrument. In
addition, reagent costs for automated testing are
frequently higher than for manual testing, which
could restrain market revenue growth.
www.emergenresearch.com
6
Market Summary

• Some Key Highlights From the Report
• On 7 September 2022, Grifols, a major global
  player in plasma medicines, announced to sign a
  long-term agreement with Canadian Blood Services,
  Canada's national blood authority, to
  significantly increase Canada's self-sufficiency
  in immunoglobulin (Ig) medicines, which are
  significant plasma-protein treatments used to
  address various immunodeficiency as well as other
  health problems.
• The instruments segment is expected to account
  for largest revenue share during the forecast
  period. This is due to technological advancements
  in PBM systems. Development of new automated and
  semi-automatic agglutination techniques, which
  are quickly replacing manual tube procedures, is
  majorly due to their versatility, efficacy, and
  dependability. Transfusion services can modify
  their systems based on workload in addition to
  these therapeutic advantages owing to automated
  solutions.
• The whole blood red blood cells segment is
  expected to register fastest revenue growth rate
  during the forecast period. This is due to
  increasing number of traffic accidents. As an
  illustration, almost 90 of fatal car accidents
  occur in low- and middle-income countries. A
  staggering 50 of fatalities caused by bleeding
  takes place during the first 24 hours after being
  brought to emergency room. In addition, 70 of
  all blood transfusions at trauma centers are
  performed on trauma patients, in need of hospital
  resources. Thus, increasing requirement of whole
  blood and blood transfusion, is driving revenue
  growth of this segment.
• Request Free Sample Copy_at_ https//www.emergenresea
  rch.com/request-sample/1757

www.emergenresearch.com
7
Market Summary
Emergen Research has segmented the global
antibacterial susceptibility testing market based
on product, component, end-use, and
region Product Outlook (Revenue, USD Billion
20192032) Instruments Blood Processing
Devices Centrifuge Blood Cell Processors Component
Outlook (Revenue, USD Billion 20192032) Whole
Blood Cells (WBC) and Red Blood Cells
(RBC) Plasma End-Use Outlook (Revenue, USD
Billion 20192032) Hospitals Blood
Banks Diagnostic Clinics Pathology Labs Read
More_at_ https//www.emergenresearch.com/industry-rep
ort/patient-blood-management-market
8
Parameter Details
Market Size Estimation Period 2023-2032
Base Year Considered 2022
Historical Data 2019-2021
Forecast Period 2023-2032
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
9
Regional Share Dynamics
www.emergenresearch.com
10
LATEST PUBLICATIONS
Latest published reports by Emergen Research
Point-Of-Sale Security Market https//www.emerge
nresearch.com/industry-report/point-of-sale-securi
ty-market   Smart Insulin Delivery Patch
Market https//www.emergenresearch.com/industry-re
port/smart-insulin-delivery-patch-market   Enterpr
ise Information Archiving Market https//www.emerg
enresearch.com/industry-report/enterprise-informat
ion-archiving-market   Public Safety and Security
Market https//www.emergenresearch.com/industry-re
port/public-safety-and-security-market   Patient
Blood Management Market https//www.emergenresearc
h.com/industry-report/patient-blood-management-mar
ket  
www.emergenresearch.com
11
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
www.emergenresearch.com
12
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 [phone]